Zoetis
Apoquel 5.4 mg for dogs 100 tablets

Treatment of pruritus (itching) associated with allergic dermatitis in dogs

Some countries require a prescription to be issued for the sale of this drug.

Apoquel 5.4 mg are some white to off-white, oblong shaped film-coated tablets with a score-line on both sides and marked with the letter "M" on both sides for the treatment of pruritus (itching) associated with allergic dermatitis in dogs.

Each Apoquel 5.4 mg film-coated tablet contains:

Active substance:

  • Oclacitinib (as oclacitinib maleate) 5.4 mg

Excipients:

  • Cellulose, microcrystalline
  • Lactose monohydrate
  • Magnesium stearate
  • Sodium starch glycolate
  • Lactose monohydrate
  • Hypromellose (E464)
  • Titanium dioxide (E171)
  • Macrogol 400 (E1521)

Apoquel 5.4 mg is indicated:

Dogs:

  • Treatment of pruritus associated with allergic dermatitis in dogs.
  • Treatment of clinical manifestations of atopic dermatitis in dogs.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in dogs less than 12 months of age or less than 3 kg bodyweight.

Do not use in dogs with evidence of immune suppression, such as hyperadrenocorticism, or with evidence of progressive malignant neoplasia as the active substance has not been evaluated in these cases.

Apoquel 5.4 mg posology:

For oral use.

Dosage and treatment schedule:

The recommended initial dose is 0.4 to 0.6 mg oclacitinib/kg bodyweight, administered orally, twice daily for up to 14 days.

For maintenance therapy, the same dose (0.4 to 0.6 mg oclacitinib/kg bodyweight) should then be administered only once a day. The requirement for long-term maintenance therapy should be based on an individual benefit-risk assessment.

These tablets can be administered with or without food.

The dosing table below shows the number of tablets required. The tablets are breakable along the score line.

Bodyweight (kg)of dog Tablets to be administered
13.5-19.9 kg ½
27.0-39.9 kg 1
40.0-54.9 kg 1 ½
55.0-80.0 kg 2

Apoquel 5.4 mg are some white to off-white, oblong shaped film-coated tablets with a score-line on both sides and marked with the letter "M" on both sides for the treatment of pruritus (itching) associated with allergic dermatitis in dogs.

Each Apoquel 5.4 mg film-coated tablet contains:

Active substance:

  • Oclacitinib (as oclacitinib maleate) 5.4 mg

Excipients:

  • Cellulose, microcrystalline
  • Lactose monohydrate
  • Magnesium stearate
  • Sodium starch glycolate
  • Lactose monohydrate
  • Hypromellose (E464)
  • Titanium dioxide (E171)
  • Macrogol 400 (E1521)

Apoquel 5.4 mg is indicated:

Dogs:

  • Treatment of pruritus associated with allergic dermatitis in dogs.
  • Treatment of clinical manifestations of atopic dermatitis in dogs.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in dogs less than 12 months of age or less than 3 kg bodyweight.

Do not use in dogs with evidence of immune suppression, such as hyperadrenocorticism, or with evidence of progressive malignant neoplasia as the active substance has not been evaluated in these cases.

Apoquel 5.4 mg posology:

For oral use.

Dosage and treatment schedule:

The recommended initial dose is 0.4 to 0.6 mg oclacitinib/kg bodyweight, administered orally, twice daily for up to 14 days.

For maintenance therapy, the same dose (0.4 to 0.6 mg oclacitinib/kg bodyweight) should then be administered only once a day. The requirement for long-term maintenance therapy should be based on an individual benefit-risk assessment.

These tablets can be administered with or without food.

The dosing table below shows the number of tablets required. The tablets are breakable along the score line.

Bodyweight (kg)of dog Tablets to be administered
13.5-19.9 kg ½
27.0-39.9 kg 1
40.0-54.9 kg 1 ½
55.0-80.0 kg 2
142.70
Order within 20h 49m 18s (before 12AM)
And receive your order
on Wednesday 25 October
AIR FREIGHT

Customers who buy this product, usually buy: